Speaker illustration

Ms Alexandra van Dissel

Amsterdam UMC - Location Academic Medical Center, Amsterdam (Netherlands (The))

Early experience with selexipag for the treatment of adults with pulmonary arterial hypertension associated with congenital heart disease

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pharmacotherapy

Session: Congenital Heart Disease and Pediatric Cardiology ePosters

Thumbnail

Refining the 2015 European guidelines risk assessment tool for pulmonary arterial hypertension in adult congenital heart disease

Event: ESC CONGRESS 2019

Topic: Adult Congenital Heart Disease (ACHD)

Session: Clinical aspects in congenital heart disease

Thumbnail

Repeated measurements of cardiac biomarkers for risk prediction in pulmonary arterial hypertension associated with congenital heart disease: a 10-year observational cohort study

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Risk stratification in congenital heart disease

Thumbnail

Systemic right ventricular function: temporal trends and risk for events

Event: ESC Congress 2018

Topic: Cardiac Magnetic Resonance (CMR)

Session: Congenital heart disease diagnostic aspects

Thumbnail

A congenital anomaly underlying mitral valve disease.

Event: ESC Congress 2018

Topic: Clinical

Session: Squaring the circle: from congenital to acquired complex valvular and myocardial disease

Thumbnail

QRS complex in adults with systemic right ventricles: signs of poor prognosis

Event: ESC CONGRESS 2017

Topic: Grown-up congenital heart disease and surgery

Session: Novel insights in congenital heart disease

Thumbnail

A multi-biomarker model identifies patients with PAH-CHD at highest risk for mortality

Event: ESC CONGRESS 2017

Topic: Grown-up congenital heart disease and surgery

Session: Novel insights in congenital heart disease

Thumbnail

Long-term clinical outcomes of a randomized controlled trial comparing valsartan to placebo in patients with systemic right ventricles

Event: ESC CONGRESS 2017

Topic: Grown-up congenital heart disease and surgery

Session: Contemporary management of risk factors in congenital heart disease

Thumbnail

This platform is supported by

logo Novo Nordisk